UNIVERSITE CLAUDE BERNARD LYON 1;INSTITUTE NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM);CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
发明人:
Manuel ROSA-CALATRAVA,Olivier TERRIER,Anaïs PROUST,Vincent MOULES
申请号：
US16340346
公开号：
US20190307722A1
申请日:
2017.10.20
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to a pharmaceutical or veterinary composition for its use in preventing and/or treating a MERS-CoV (Middle-East Respiratory Syndrome) coronavirus infection, characterised in that it comprises, in a suitable pharmaceutical vehicle, at least one compound chosen from apigenin and berberine.
